Development of medical devices (drug-eluting and bone marrow mononuclear cell separation equipment)
First written in FY2020. 6 of 7 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「In April 2026, we submitted a plan for the provision of regenerative medicine and other medical care to a certified special committee for regenerative medicine and other medical care in preparation for conducting clinical research using this prototype device, and we are proceeding with preparations for its introduction at hospitals.」
For the stem cell isolation system, the company has advanced beyond improving the prototype's stable operation and reproducibility to submitting a plan for clinical research and preparing for hospital implementation. - FY2024AdvancedAnnual report
「We commercialized the mononuclear cell separation device “MK-1000,” on which it is based.」
Based on the results of research and development of a stem-cell separation device for ischemic stroke treatment, the company commercialized the mononuclear cell separation device MK-1000. It has indicated a policy of pursuing applications in dementia treatment and other areas. - FY2022AdvancedAnnual report
「“Research and development of an efficient stem-cell separation device for optimized ischemic stroke treatment based on the treatment mechanism” Fiscal 2021–Fiscal 2023 “Strategic Promotion Program for Translational Research,” Japan Agency for Medical Research and Development (AMED): Fiscal 2021–Fiscal 2023」
Joint development of a stem-cell separation device for ischemic stroke treatment continues as an AMED project for fiscal 2021–fiscal 2023. The drug-release device manufacturing equipment is at the prototype development stage, with the aim of applying it to a Phase 2 clinical trial. - FY2022-Q2AdvancedAnnual report
「In addition to the large-scale automated cell culture system KB-4000 and MakCell, sales of prototype drug-release device manufacturing equipment under development contributed to results in the second quarter.」
In medical-device development, drug-release device manufacturing equipment has progressed to the stage of recognizing sales of prototypes under research and development. - FY2020First statedAnnual report
「We are pursuing joint research with universities and research institutions with the aim of manufacturing and marketing medical devices.」
The company describes a new medical-device development initiative involving joint research with the Faculty of Medicine at Tohoku University on drug-release device manufacturing equipment and with the Foundation for Biomedical Research and Innovation at Kobe on bone-marrow mononuclear cell separation equipment.